Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
July 16 2018
Audience prize-DEFYMED-MedFIT2018 Strasbourg, June 26-27th 2018: MedFIT 2018, a European business co...
June 15 2018
Strasbourg, June 26-27th 2018: We are happy to announce that Defymed won the “Start-up Slams” and i...